Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd ( (AU:OSL) ) has shared an update.
OncoSil Medical Ltd has announced the application for quotation of new securities on the ASX. The company is set to quote 1,719,306 ordinary fully paid securities and an equal number of options expiring on July 31, 2027. This move is part of their strategic efforts to enhance their market presence and potentially increase funding for ongoing and future projects.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of innovative medical devices. The company primarily offers products aimed at treating cancer, with a market focus on providing advanced treatment options for patients.
Average Trading Volume: 40,604
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$17.7M
For detailed information about OSL stock, go to TipRanks’ Stock Analysis page.